EX-99.02 10 ex9902.htm CASPI FINANCIAL INFORMATION CASPI Financial Information
 
EXHIBIT 99.02
   
   

TABLE 4a- EASTMAN CHEMICAL COMPANY DETAIL OF SALES REVENUE

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2005
 
2005
 
2005
 
2005
 
2005
                     
Sales Revenue
$
1,762
$
1,752
$
1,816
$
1,729
$
7,059
Less: CASPI restructured, divested, and consolidated product lines (1)
 
--
 
--
 
--
 
--
 
--
Sales revenue - continuing product lines
$
1,762
$
1,752
$
1,816
$
1,729
$
7,059
                     


   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2004
 
2004
 
2004
 
2004
 
2004
                     
Sales Revenue
$
1,597
$
1,676
$
1,649
$
1,658
$
6,580
Less: CASPI restructured, divested, and consolidated product lines (1)
 
174
 
193
 
74
 
--
 
441
Sales revenue - continuing product lines
$
1,423
$
1,483
$
1,575
$
1,658
$
6,139
                     

TABLE 4b- EASTMAN DIVISION DETAIL OF SALES REVENUE

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2005
 
2005
 
2005
 
2005
 
2005
                     
Sales Revenue
$
885
$
902
$
940
$
917
$
3,644
Less: CASPI divested/consolidated product lines (1)
 
--
 
--
 
--
 
--
 
--
Sales revenue - continuing product lines
$
885
$
902
$
940
$
917
$
3,644
                     

   
First Quarter
 
Second Quarter
 
Third Quarter
 
Fourth Quarter
 
Twelve Months
(Dollars in millions)
 
2004
 
2004
 
2004
 
2004
 
2004
                     
Sales Revenue
$
886
$
943
$
892
$
824
$
3,545
Less: CASPI divested/consolidated product lines (1)
 
174
 
193
 
74
 
--
 
441
Sales revenue - continuing product lines
$
712
$
750
$
818
 
824
$
3,104
                     
                     

(1) These businesses and product lines include acrylate ester monomers, composites (unsaturated polyester resins), inks and graphic arts raw materials, liquid resins, powder resins and textile chemicals divested on July 31, 2004 as well as other restructuring, divestiture and consolidation activities that the Company has completed related to these businesses and product lines.
 
141